Blog
RSS FeedPosted by Michael Wonder on 02 Dec 2019
Biosimilar trastuzumab on the PBS - information for health professionals and patients
2 December 2019 - A new biosimilar brand of trastuzumab (Kanjinti) has listed on the PBS on 1 December 2019. ...
Posted by Michael Wonder on 14 Nov 2019
Biosimilar rituximab and insulin glargine on the PBS and other PBS Listing changes - information for health professionals and patients
14 November 2019 - Biosimilar brands of rituximab (Riximyo) and insulin glargine (Semglee) have listed on the PBS on 1 October ...
Posted by Michael Wonder on 02 Aug 2019
Mylan and Biocon launch first trastuzumab biosimilar Ogivri in Australia
1 August 2019 - Biocon and Mylan today announced the launch in Australia of Ogivri (trastuzumab), a biosimilar to Herceptin ...
Posted by Michael Wonder on 04 Jun 2019
Biosimilar uptake drivers - etanercept
3 June 2019 - Information about Government initiatives to encourage the use of biosimilars is now available on the PBS website. ...
Posted by Michael Wonder on 13 May 2019
Australia's GBMA launches hub for biosimilar education
13 May 2019 - In 2018, the Generic Biosimilar Medicines Association was awarded the Biosimilar Education Grant by the Australian government ...
Posted by Michael Wonder on 05 Feb 2019
Biosimilar uptake drivers
5 February 2019 - Information about Government initiatives to encourage the use of biosimilars is now available on the PBS website. ...
Posted by Michael Wonder on 06 Oct 2018
Global moves to reduce the future cost of publicly funded medicines
5 October 2018 - The most significant advances in medical treatments are being made with biological products that are significantly ...
Posted by Michael Wonder on 18 Sep 2018
Changes to TGA/PBAC parallel processing arrangements for biosimilar medicines
18 September 2018 - Submissions requesting the listing of a new biosimilar medicine are no longer eligible to be submitted under ...
Posted by Michael Wonder on 03 Sep 2018
Biosimilar awareness initiative – literature review
3 September 2018 - The biosimilar literature review update for the period March 2018 to May 2018 is now available. ...
Posted by Michael Wonder on 04 Jul 2018
PBAC to adopt a revised approach to considering brand equivalence/substitution for biosimilar medicines
4 July 2018 - PBAC to consult with Medicines Australia on the possible withdrawal of the TGA-PBAC parallel process for ...
Posted by Michael Wonder on 23 Apr 2018
Biosimilar education grant
23 April 2018 - A grant has been awarded to GBMA Education Limited to complement and extend the activities undertaken by ...
Posted by Michael Wonder on 20 Dec 2017
Agenda for the March 2018 PBAC meeting
20 December 2017 - The agenda for the March 2018 PBAC meeting is now available. ...
Posted by Michael Wonder on 02 Dec 2017
Public Summary Documents - August 2017 PBAC meeting
1 December 2017 - The public summary document for etanercept from the August 2017 PBAC meeting is now available. ...
Posted by Michael Wonder on 30 Nov 2017
Which biosimilar medicines are available in Australia?
30 November 2017 - Information is available on the Department of Health website setting out the biosimilar brands of medicines which ...
Posted by Michael Wonder on 24 Oct 2017
AMA submission - Government proposals to increase biosimilar prescribing
19 October 2017 - The Australian Medical Association encourages medical practitioners to offer generic medicine choices when it is safe and ...